SKI Market

Indian Indices

Sensex

84,929.36 447.55
( 0.53%)

Global Indices

Nasdaq

48,160.46 187.60
(0.39%)

Dow Jones

6,855.87 60.11
(0.88%)

Hang Seng

49,620.18 618.68
(1.26%)

Nikkei 225

9,885.23 47.46
(0.48%)

Forex

USD-INR

90.25 -0.22
(-0.24%)

EUR-INR

105.87 -0.28
(-0.27%)

GBP-INR

120.72 -0.26
(-0.21%)

JPY-INR

0.58 0.00
(-0.44%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Akiko Global Services Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

92712

INE0PMR01017

38.8026482

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AKIKO

47.02

280.01

EPS(TTM)

Face Value()

Div & Yield %

5.53

Back

usg tech solutions ltd

Concord Biotech standalone net profit declines 36.27% in the September 2025 quarter

Nov 15,2025

Net profit of Concord Biotech declined 36.27% to Rs 62.90 crore in the quarter ended September 2025 as against Rs 98.70 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	247.06	310.18	-20
OPM %	36.65	44.06	-
PBDT	103.92	146.60	-29
PBT	85.53	133.29	-36
NP	62.90	98.70	-36

84,929.36 447.55 ( 0.53%)

48,160.46 187.60 (0.39%)

6,855.87 60.11 (0.88%)

49,620.18 618.68 (1.26%)

9,885.23 47.46 (0.48%)

90.25 -0.22 (-0.24%)

105.87 -0.28 (-0.27%)

120.72 -0.26 (-0.21%)

0.58 0.00 (-0.44%)